Preclinical Assessment of CDR101 - a BCMAxCD3xPD-L1 Trispecific Antibody with Superior Anti-Tumor Efficacy
Vrohlings, Melissa, Müller, Jan, Jungmichel, Stephanie, Senn, David, Howald, Anna Bianca, Schleier, Thomas, Scheifele, Fabian, Wendelspiess, Severin, Richle, Philipp, Merten, Hannes, Lenherr-Frey, Daniel, Leisner, Christian, Manz, Markus G, Borras, Leonardo J.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article